Access to Breast Cancer Diagnosis Act of 2025
Senate Bill Would Eliminate Out-of-Pocket Costs for Follow-Up Breast Cancer Tests
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- Would ban deductibles, copays, and coinsurance for follow-up breast cancer tests in most private health plans.
- Covers “diagnostic” exams (like a diagnostic mammogram, breast MRI, or ultrasound) when something looks suspicious on a screening or other exam.
- Covers “supplemental” exams (like MRI or ultrasound) for higher-risk people even when nothing looks abnormal on a screening.
- Plans could still require prior approval and other reasonable limits, and state laws with stronger protections would still apply.
- Starts for plan years beginning on or after January 1, 2026, and includes older “grandfathered” plans; keeps HSA-eligible plans from losing status.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
3 articlesLawmakers anxious to advance breast cancer bill — when shutdown ends
Reps. Debbie Dingell and Beth Van Duyne discussed how the government shutdown is halting progress on the bipartisan Access to Breast Cancer Diagnosis Act. The bill seeks to eliminate out-of-pocket costs for follow-up diagnostic tests, a move supported by 90% of Republican voters in recent polls.
Bipartisan Bill Reintroduced to Eliminate Cost Barriers for Supplemental Breast Imaging
Lawmakers have reintroduced the Access to Breast Cancer Diagnosis Act, which would mandate that health insurers cover supplemental imaging services like MRI and ultrasound without patient cost-sharing. The bill aims to close the gap where follow-up tests are often not covered by the ACA.
Bipartisan bill would require insurers to cover supplemental breast imaging nationwide
The Access to Breast Cancer Diagnosis Act, led by Reps. Dingell and Fitzpatrick, seeks to eliminate financial barriers to diagnostic imaging. While screening mammograms are covered under current law, follow-up tests can cost patients over $1,000, leading many to forgo necessary care.
Source Information
Document Type
Congressional Bill
Official Title
Access to Breast Cancer Diagnosis Act of 2025
Data Sources
Sponsor
Cosponsors
(6)Analysis generated by AI. Always verify with official sources.